Vineet Laboratories Ltd - Stock Valuation and Financial Performance

BSE: 543298 | NSE: VINEETLAB | Pharmaceuticals & Drugs | Small Cap

Vineet Laboratories Share Price

42.03 0.53 1.28%
as on 21-Feb'25 16:59

DeciZen - make an informed investing decision on Vineet Laboratories

M-Cap below 100cr DeciZen not available

Vineet Laboratories stock performance -

P/E Ratio (SA):
0.00
Market Cap:
38.8 Cr.
52-wk low:
38.5
52-wk high:
78.5

Is Vineet Laboratories Ltd an attractive stock to invest in?

1. Is Vineet Laboratories Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Vineet Laboratories Ltd is a below average quality company.

2. Is Vineet Laboratories Ltd undervalued or overvalued?

The key valuation ratios of Vineet Laboratories Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Vineet Laboratories Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Vineet Laboratories Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Vineet Laboratories:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Vineet Laboratories Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 0%0%-2.9%34.1%23.1%8.7%7.2%-
Value Creation
Index
NANA-1.21.40.7-0.4-0.5-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 00024319121215198
Sales YoY Gr.-NANANA-21.5%11.1%-29.1%-
Adj EPS 00-0.31.77.11.61.1-8.4
YoY Gr.-NANANA314.5%-77.3%-31.5%-
BVPS (₹) -3.99.19.728.93636.537.727.2
Adj Net
Profit
0001.66.61.51-8
Cash Flow from Ops. 00027.57.6-9.6-11.4-
Debt/CF from Ops. 0000.53.5-3.2-3.9-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANA-14.8%-29.1%
Adj EPS NANA-13.6%-31.5%
BVPSNA32.8%9.3%3.1%
Share Price - - -10.9% -32.1%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
00-2.811.8224.53-25.9
Op. Profit
Mgn %
0003.46.93.84.8-1.9
Net Profit
Mgn %
0000.73.40.70.7-7.9
Debt to
Equity
0000.50.80.91.30.2
Working Cap
Days
00065172156215309
Cash Conv.
Cycle
00018325110937

Recent Performance Summary

No data to display

Return on Equity is Poor

Sales growth has been subdued in last 3 years -14.80%

Debt to equity has increased versus last 3 years average to 1.28

Sales growth is not so good in last 4 quarters at -43.12%

Latest Financials - Vineet Laboratories Ltd.

Standalone Consolidated
TTM EPS (₹) -8.4 -
TTM Sales (₹ Cr.) 98 -
BVPS (₹.) 27.2 -
Reserves (₹ Cr.) 16 -
P/BV 1.55 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 38.45 / 78.48
All Time Low / High (₹) 38.20 / 124.70
Market Cap (₹ Cr.) 38.8
Equity (₹ Cr.) 9.2
Face Value (₹) 10
Industry PE 37.5

Quarterly Results

 Mar'24 YoY Gr. Rt. %Jun'24 YoY Gr. Rt. %Sep'24 YoY Gr. Rt. %Dec'24 YoY Gr. Rt. %
Sales (₹ Cr.) 37.1 -35.223.9 -36.419 -56.318.1 -44.6
Adj EPS (₹) 2.1 -45.7-2.3 N/A-2 -175.6-6.2 N/A
Op. Profit Mgn % 9.22 -93 bps-3.33 -402 bps-1.61 -1122 bps-22.85 -2088 bps
Net Profit Mgn % 5.19 -101 bps-8.93 -560 bps-9.64 -1521 bps-31.53 -2520 bps

Management X-Ray of Vineet Laboratories:

Shareholding Pattern

JavaScript chart by amCharts 3.21.5
JavaScript chart by amCharts 3.21.5Promoters:35.85%Institutions:0%Non-Institutions:64.15%

Promoter's Holding & Share Pledging

JavaScript chart by amCharts 3.21.5Sep22Dec22Mar23Jun23Sep23Dec23Mar24Jun24Sep24Dec240%10%20%30%40%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Vineet Laboratories

MRP
spaceLock icon
MOS
spaceLock icon%
DP
spaceLock icon
Base EPS
spaceLock icon
DPS
spaceLock icon
MRP: ₹ 0
DP: ₹0
Base EPS ₹:
DPS ₹:
MOS (%):
Expected EPS Growth Rate:
0%
Base 0%
50%
Expected Rate of Return:
0%
Base 0%
50%
Future PE:
0
Base 0
200
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max

Event Update

Login/Register to view analysis.

Analyst's Notes

No data found!

Key Ratios of Vineet Laboratories

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Company Name CMP(₹)
Change ₹(%)
Market Cap
Net Sales (₹ Cr.)
Latest EPS (₹)
Net Profit Margin %
Latest P/E
Latest P/BV
Alembic Pharma 802.8 -10.6 (-1.3%) Small Cap 6,229 30.8 9.6 26.4 3.2
Laurus Labs 521.1 -15.4 (-2.9%) Small Cap 5,041 3.7 3.1 144.5 6.9
Piramal Pharma 208.6 -9.5 (-4.3%) Small Cap 4,390 5.2 8.4 42.1 4.1
Ajanta Pharma 2,607.3 -63.1 (-2.4%) Small Cap 4,209 71.9 19 37.2 8.5
Gland Pharma 1,524.3 3.9 (0.3%) Small Cap 4,167 68.1 24.8 22.3 2.7
Natco Pharma 797.8 4.8 (0.6%) Small Cap 3,999 104.1 34.5 7.6 2
Granules India 509 -18.4 (-3.5%) Small Cap 3,755 13.3 11.7 39.7 3.9
Emcure Pharma 996.8 5.2 (0.5%) Small Cap 3,498 8.5 4.4 116.8 6.5
JB Chem & Pharma 1,605.5 -25 (-1.5%) Small Cap 3,299 40.4 16.1 40.4 7.7
Sanofi India 5,076.8 -91.3 (-1.8%) Small Cap 2,851 184.4 20.8 28 15.5
Shows rows:

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales000243.48191.17212.29150.59
Operating Expenses 000.01235.33178.01204.63143.39
Manufacturing Costs00026.5218.8318.2816.25
Material Costs000198.11145.55172.33113.92
Employee Cost 0005.574.9166.38
Other Costs 000.015.138.738.036.84
Operating Profit 00-0.018.1513.167.667.20
Operating Profit Margin (%) ---3.3%6.9%3.6%4.8%
Other Income 0000.390.290.120.46
Interest 0002.672.093.384.78
Depreciation 0001.812.022.372.52
Exceptional Items 0000000
Profit Before Tax 00-0.014.069.352.030.36
Tax 0002.282.710.78-0.66
Profit After Tax 00-0.011.786.641.251.03
PAT Margin (%) ---0.7%3.5%0.6%0.7%
Adjusted EPS (₹)0.00.0-0.31.97.21.41.1
Dividend Payout Ratio (%)0%0%0%0%14%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 0.010.410.4026.6233.2233.6834.72
Share Capital 0.010.410.419.229.229.229.22
Reserves 00-0.0117.402424.4625.51
Minority Interest0000000
Debt00012.4726.5130.0542.98
Long Term Debt0003.471.724.853.89
Short Term Debt0009.0124.7925.2039.09
Trade Payables0.010.01055.9960.0934.8932.26
Others Liabilities 0.010013.6713.4917.236.91
Total Liabilities 0.020.420.40108.74133.32115.85116.87

Fixed Assets

Gross Block00035.4839.2246.8549.64
Accumulated Depreciation00015.8217.8320.2122.73
Net Fixed Assets00019.6721.3826.6526.92
CWIP 0000000
Investments 0000.120.140.130.18
Inventories00039.6943.5446.1749.39
Trade Receivables00042.7136.2035.1631.60
Cash Equivalents 00.0102.1018.120.950.44
Others Assets0.020.410.404.4613.946.798.34
Total Assets 0.020.420.40108.74133.32115.85116.87

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 00027.497.63-9.62-11.43
PBT 00-0.014.069.352.030.36
Adjustment 0005.713.905.971.97
Changes in Working Capital 000.0116.87-2.43-14.63-13.5
Tax Paid 0000.85-3.18-2.99-0.25
Cash Flow From Investing Activity 000-7.81-3.68-6.690.33
Capex 000-7.850-7.63-0.23
Net Investments 0000-3.8400
Others 0000.050.160.950.57
Cash Flow From Financing Activity 00018.6211.960.2710.69
Net Proceeds from Shares 0008.81000
Net Proceeds from Borrowing 000014.044.17-0.69
Interest Paid 000-2.67-2.09-3.38-2.52
Dividend Paid 00000-0.920
Others 00012.4700.4113.90
Net Cash Flow 00038.3015.91-16.03-0.40
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)00-2.8713.1822.193.743
ROCE (%)00-2.8734.0623.148.697.16
Asset Turnover Ratio0004.461.581.71.29
PAT to CFO Conversion(x)N/AN/AN/A15.441.15-7.7-11.1
Working Capital Days
Receivable Days00064756181
Inventory Days000597977116
Payable Days00052146101108

Vineet Laboratories Ltd Stock News

Vineet Laboratories Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Vineet Laboratories on 21-Feb-2025 16:59 is ₹42.03.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 21-Feb-2025 16:59 the market cap of Vineet Laboratories stood at ₹38.75.
The latest P/E ratio of Vineet Laboratories as of 21-Feb-2025 16:59 is 0.00.
The latest P/B ratio of Vineet Laboratories as of 21-Feb-2025 16:59 is 1.55.
The 52-week high of Vineet Laboratories is ₹78.48 and the 52-week low is ₹38.45.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Vineet Laboratories is ₹97.97 ( Cr.) .

About Vineet Laboratories Ltd

Vineet Laboratories Limited (Formerly Known As Ortin Laboratories Limited, Unit-II) is public company domiciled in India and incorporated under the provisions of Companies Act, 2013 applicable in India and it was incorporated in India on November 10, 2016 having its Registered office at Saheb Nagar, Kurdu Vill, Chintal Kunta, Eshwaramma Nilayam, L B Nagar, Hyderabad, Telangana. The shares of the company are listed on Bombay Stock Exchange and National Stock Exchange.

Business area of the company

The company is engaged in the business of Drug Intermediates & Bulk Dugs.

Product and services

  • API Intermediates
  • Fine Chemicals and Reagents
  • Research & Development
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Loading...
Hold on